Royal Peptides
Royal Peptides supplies research compounds to qualified adults for in-vitro laboratory use. Confirm both requirements to enter.
Royal Peptides is only for adults 21+ buying for laboratory research.
Leave this site
Royal Peptides products are offered exclusively for laboratory research, analytical and scientific applications. Not for human or veterinary use.
Royal Peptides supplies compounds intended for controlled laboratory research and analytical applications.
Research onlyLaboratory materialAnalytical use
Where applicable, Royal Peptides research materials are supplied in lyophilized form. Lyophilization is a freeze-drying process used to remove moisture from material under controlled conditions.
Storage requirements may vary by compound, formulation and production lot. Refer to the product label and available product-specific documentation.
Packaging components may vary slightly between production lots. This can include vial closures, cap styles, label positioning and external packaging.
Research noticeFor laboratory and research purposes only. Not intended for human consumption, diagnostic or therapeutic use, or administration to humans or animals.
KPV is a short three-amino-acid peptide sequence composed of lysine, proline, and valine. It is studied in controlled experimental systems involving peptide signaling, molecular interactions, cellular response pathways, and structure-function relationships.
Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.
KPV is a tripeptide consisting of the amino-acid sequence lysine-proline-valine. Its compact three-residue structure makes it a distinct research material for biochemical, molecular, and cellular investigation.
KPV is also recognized in scientific literature as a peptide sequence associated with the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH), providing an established structural context for laboratory investigation.
Royal Peptides supplies KPV strictly as a laboratory research material. Scientific information presented here describes compound identity and areas of experimental investigation only.
KPV is identified by a concise three-amino-acid sequence. This defined structure provides a straightforward molecular identity for analytical characterization and controlled peptide research.
The KPV sequence consists of three defined amino-acid residues. Researchers may examine this compact peptide in relation to molecular identity, structural characteristics, peptide-target interactions, and experimentally measurable signaling processes.
Lysine forms the first residue in the defined KPV tripeptide sequence.
Proline occupies the central position within the three-residue KPV sequence.
Valine completes the C-terminal position of the KPV tripeptide sequence.
Together, lysine, proline, and valine form the molecular sequence identified as KPV.
KPV appears in experimental literature examining peptide signaling and molecular response pathways. These research areas describe laboratory investigation and should not be interpreted as intended therapeutic or clinical uses of this material.
Experimental systems may investigate KPV in relation to defined peptide-associated signaling pathways and measurable molecular responses.
Controlled laboratory models may be used to characterize interactions between KPV and selected molecular targets.
KPV may be incorporated into appropriately designed experimental systems examining measurable cellular response variables.
Its compact three-residue sequence provides a defined material for comparative investigations involving peptide structure and molecular function.
Laboratory evaluation should rely on documentation associated with the specific KPV production lot under investigation. General product-page information should not replace applicable batch-specific analytical records.
Appropriate laboratory records help maintain traceability between experimental observations and the specific KPV production lot incorporated into a research workflow.
Record the KPV identity, stated material quantity, applicable production lot or batch reference, date received, and relevant internal laboratory identifier.
Preserve applicable analytical documentation, experimental observations, results, storage records, and other research records associated with the material.
KPV research material should be handled using appropriate laboratory procedures designed to preserve material identity, minimize contamination, and maintain experimental traceability.
Handle using appropriate laboratory practices and equipment. Maintain clear material identification throughout receipt, storage, analytical preparation, and experimental workflows.
Follow storage information associated with the applicable product label and batch documentation. Maintain appropriate laboratory storage and material-control records.
Royal Peptides KPV is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.
KPV is a three-amino-acid peptide sequence composed of lysine, proline, and valine. Royal Peptides supplies it strictly as a laboratory research material.
K, P, and V are the standard one-letter amino-acid abbreviations for lysine, proline, and valine respectively.
KPV contains three amino-acid residues and is therefore classified as a tripeptide.
KPV is recognized in scientific literature as a short C-terminal peptide sequence associated with alpha-melanocyte-stimulating hormone. This relationship provides structural and molecular context for experimental peptide research.
Experimental research involving KPV includes investigation of peptide signaling, molecular interactions, cellular response pathways, and peptide structure-function relationships. These are research contexts, not intended uses of this product.
No. Royal Peptides supplies KPV strictly for laboratory research. It is not intended for human or veterinary administration.
No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for KPV.
Batch-specific analytical documentation corresponds to a particular production lot. Recording the applicable lot reference supports traceability between the research material, analytical documentation, and laboratory records.
Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.
KPV is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
| PubChem CID | 13294447 |
|---|---|
| Application | Experimental inflammatory signaling research |
| Also known as | Lys-Pro-Val |
| Sequence | KPV |
| Molecular formula | C11H12O3 |
| Molecular weight | 192.21 g/mol |
| CAS number | 88768-11-0 |
| Purity specification | ≥99% |
| Form | Lyophilized powder |
| Storage | Store at −20°C |
Independent lab results for each lot. Match the lot number on your vial to its report.
View KPV COAs →Orders placed before the daily cut-off ship the same business day when in stock, in plain, secure packaging with tracking.
Store unopened vials frozen (−20 °C), protected from light and moisture. Follow the storage conditions on the product label and the batch COA.
| PubChem CID | 13294447 |
|---|---|
| Application | Experimental inflammatory signaling research |
| Also known as | Lys-Pro-Val |
| Sequence | KPV |
| Molecular formula | C11H12O3 |
| Molecular weight | 192.21 g/mol |
| CAS number | 88768-11-0 |
| Purity specification | ≥99% |
| Form | Lyophilized powder |
| Storage | Store at −20°C |
